Hydroxycarbamide (INN, BAN) or hydroxyurea (USAN, AAN) (trade names include Hydrea, Litalir, and Droxia) is an antineoplastic drug used in myeloproliferative disorders, specifically polycythemia vera and essential thrombocythemia. It is also used to reduce the rate of painful attacks in sickle-cell disease and has antiretroviral properties in diseases such as HIV/AIDS.Reported side-effects are: drowsiness, nausea, vomiting and diarrhea, constipation, mucositis, anorexia, stomatitis, bone marrow toxicity (dose-limiting toxicity; may take 7–21 days to recover after the drug has been discontinued), alopecia (hair loss), skin changes, abnormal liver enzymes, creatinine and blood urea nitrogen.
On Dec, 21, 2015: 3,288 people reported to have side effects when taking Hydroxyurea. Among them, 23 people (0.70%) have Hallucination.
Time on Hydroxyurea when people have Hallucination :
|
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
Hallucination |
100.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
On Dec, 17, 2015: 3,288 people reported to have side effects when taking Hydroxyurea. Among them, 119 people (3.62%) have Death.
Time on Hydroxyurea when people have Death :
|
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
Death |
0.00% |
12.50% |
0.00% |
0.00% |
62.50% |
25.00% |
0.00% |
Gender of people who have Death when taking Hydroxyurea :
|
Female |
Male |
Death |
46.08% |
53.92% |
Age of people who have Death when taking Hydroxyurea :
|
0-1 |
2-9 |
10-19 |
20-29 |
30-39 |
40-49 |
50-59 |
60+ |
Death |
0.00% |
0.00% |
1.30% |
3.90% |
7.79% |
10.39% |
24.68% |
51.95% |